Manulife (Manufacturers Life Insurance)’s aTyr Pharma ATYR Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio ATYR Stock Details ATYR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8.23K	Buy	+10,552	New	+$8.91K	﹤0.01%	2803
2025 Q3	–	Sell	-32,477	Closed	-$165K	–	3006
2025 Q2	$165K	Buy	+32,477	New	+$128K	﹤0.01%	2632
2018 Q3	–	Sell	-100	Closed	-$1K	–	3909
2018 Q2	$1K	Hold	100	–	–	﹤0.01%	4266
2018 Q1	$4K	Hold	100	–	–	﹤0.01%	4164
2017 Q4	$5K	Buy	+100	New	+$6.15K	﹤0.01%	4143
2017 Q3	–	Sell	-54	Closed	-$3K	–	4354
2017 Q2	$3K	Sell	54 -3	-5%	-$140	﹤0.01%	4063
2017 Q1	$3K	Hold	57	–	–	﹤0.01%	3889
2016 Q4	$2K	Hold	57	–	–	﹤0.01%	4131
2016 Q3	$3K	Hold	57	–	–	﹤0.01%	4014
2016 Q2	$2K	Sell	57 -76	-57%	-$3.53K	﹤0.01%	4025
2016 Q1	$9K	Buy	133 +76	+133%	+$5.78K	﹤0.01%	3663
2015 Q4	$8	Hold	57	–	–	﹤0.01%	3585
2015 Q3	$8	Hold	57	–	–	﹤0.01%	3595
2015 Q2	$15	Buy	+57	New	+$17.7K	﹤0.01%	3499

Other funds holding ATYR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s ATYR Position: Q1 2026 in Review

Manulife (Manufacturers Life Insurance) opened a new position in aTyr Pharma (ATYR) in Q1 2026: 10,552 shares worth $8.23K. The stake represents ﹤0.01% of the portfolio and ranks #2803 among its holdings. This is a return to the name: Manulife (Manufacturers Life Insurance) previously reported a position in ATYR as recently as Q2 2025.

Manulife (Manufacturers Life Insurance) first reported a position in ATYR in Q2 2015 and has held it in 14 quarters since. The position peaked at $165K in Q2 2025. 111 funds tracked by Wall St. Rank hold ATYR as of Q1 2026.

Manulife (Manufacturers Life Insurance) held 10,552 shares of aTyr Pharma worth $8.23K as of Q1 2026.
aTyr Pharma was a new Manulife (Manufacturers Life Insurance) position in Q1 2026.
aTyr Pharma made up ﹤0.01% of Manulife (Manufacturers Life Insurance)'s portfolio in Q1 2026, its #2803 holding.
Manulife (Manufacturers Life Insurance) first reported a position in aTyr Pharma in Q2 2015 and has held it in 14 quarters since.
Manulife (Manufacturers Life Insurance)'s aTyr Pharma position peaked at $165K in Q2 2025.
111 funds tracked by Wall St. Rank held aTyr Pharma as of Q1 2026.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q1 2026, filed 15 May 2026.